Replies to post #45305 on Anavex Life Sciences Corp (AVXL)

[TrueTrades]

It looks like I am confusing myself and blurring the distinction between seeking FDA approval of A2-73 and patent approval of the PLUS formulation. That was not my intention. We are not looking to gain FDA approval of ANAVEX PLUS, merely ANAVEX 2-73...correct? Approval of A2-73 allows it to be prescribed off-label with any already approved medication.

We can't get FDA approval for straight A2-73

I am definitely confused about how these trial results could show a distinction between the A2-73 only and PLUS results, as they are not presented separately.

I remember Dr Missling being asked a verbal question at the end of the Ladenburg Thalmann presentation about the trial being A2-73 alone, plus donepezil, or both...and not giving a particularly straight answer. :-)
§AVXL